2-((4-(2,3-Dimethylphenyl)-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid
98%
- Product Code: 192256
CAS:
637325-53-2
| Molecular Weight: | 345.44 g./mol | Molecular Formula: | C₁₆H₁₅N₃O₂S₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD04444541 | |
| Melting Point: | Boiling Point: | 609.8±65.0 °C(Predicted) | |
| Density: | 1.40±0.1 g/cm3(Predicted) | Storage Condition: | 2-8°C, away from light, dry |
Product Description:
Used in pharmaceutical research as a key intermediate in the development of anti-inflammatory and analgesic agents. Its structure supports activity in modulating enzyme pathways involved in pain and swelling. Shows potential in the design of new cyclooxygenase (COX) inhibitors, offering a pathway for safer non-steroidal anti-inflammatory drugs (NSAIDs) with reduced gastrointestinal side effects. Also investigated for antimicrobial properties, particularly against gram-positive bacteria and certain fungal strains. Employed in structure-activity relationship (SAR) studies to optimize triazole-based drug candidates for improved metabolic stability and target selectivity.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 G | 10-20 days | ฿12,390.00 |
+
-
|
| 0.010 G | 10-20 days | ฿20,960.00 |
+
-
|
| 0.025 G | 10-20 days | ฿39,830.00 |
+
-
|
| 0.050 G | 10-20 days | ฿67,670.00 |
+
-
|
| 0.100 G | 10-20 days | ฿115,010.00 |
+
-
|
2-((4-(2,3-Dimethylphenyl)-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid
Used in pharmaceutical research as a key intermediate in the development of anti-inflammatory and analgesic agents. Its structure supports activity in modulating enzyme pathways involved in pain and swelling. Shows potential in the design of new cyclooxygenase (COX) inhibitors, offering a pathway for safer non-steroidal anti-inflammatory drugs (NSAIDs) with reduced gastrointestinal side effects. Also investigated for antimicrobial properties, particularly against gram-positive bacteria and certain fungal strains. Employed in structure-activity relationship (SAR) studies to optimize triazole-based drug candidates for improved metabolic stability and target selectivity.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :